Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022

Latest Articles

  • You have access
    Dose-related statin myopathy: Is it an issue?
    Robert L. Wortmann, MD
    Cleveland Clinic Journal of Medicine September 2005, 72 (9) 751-756;

    Higher doses lead to more cases of myopathy, a potentially serious problem. Fortunately, the incidence is very low.

  • You have access
    Alopecia areata: What to expect from current treatments
    Nicole C. Dombrowski, DO and Wilma F. Bergfeld, MD
    Cleveland Clinic Journal of Medicine September 2005, 72 (9) 758-768;

    Alopecia areata often resolves on its own, but some treatment is often needed due to the psychosocial impact.

  • You have access
    Angiotensin-receptor blockers: Benefits beyond lowering blood pressure
    Russell L. Silverstein, MD and C. Venkata S. Ram, MD
    Cleveland Clinic Journal of Medicine September 2005, 72 (9) 825-832;

    These drugs improve the prognosis more than one would expect from their effect on blood pressure alone.

  • You have access
    Restless legs syndrome: Keys to recognition and treatment
    Jaime F. Avecillas, MD, Joseph A. Golish, MD, Carmen Giannini, RN, BSN and José C. Yataco, MD
    Cleveland Clinic Journal of Medicine September 2005, 72 (9) 769-787;

    Although the condition is common, a high index of suspicion is needed to diagnose it.

  • You have access
    How soon can a patient undergo noncardiac surgery after receiving a drug-eluting stent?
    Howard H. Weitz, MD
    Cleveland Clinic Journal of Medicine September 2005, 72 (9) 818-820;

    Lacking direct data, we base our approach on data from patients with bare-metal stents and from patients receiving antiplatelet therapy for acute coronary syndromes.

  • You have access
    Intravascular ultrasonography in coronary atherosclerosis trials (June 2005)
    Paolo Angelini, MD
    Cleveland Clinic Journal of Medicine September 2005, 72 (9) 745;

    Intravascular ultrasonography in coronary atherosclerosis

  • You have access
    Diagnostic imaging approach to pulmonary embolism
    Joseph W. Stengel, DO and Ruffin J. Graham, MD
    Cleveland Clinic Journal of Medicine September 2005, 72 (9) 821-824;

    A man with cancer presents with new dyspnea and low-grade fever. What is the best diagnostic approach?

  • You have access
    Malfunctions in implantable cardiac devices: Putting the risk in perspective
    J. David Burkhardt, MD and Bruce L. Wilkoff, MD
    Cleveland Clinic Journal of Medicine September 2005, 72 (9) 736-744;

    A device recall does not call for panic. Physicians should weigh the risks and benefits for the individual patient.

  • You have access
    Is a pound of prevention better than an ounce of prevention?
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine September 2005, 72 (9) 729;

    With statins, should we “start low and go slow” or adopt a new paradigm?

  • You have access
    In reply: Respiratory disorders in neuromuscular diseases (June 2005)
    Loutfi S. Aboussouan, MD
    Cleveland Clinic Journal of Medicine August 2005, 72 (8) 639;

Pages

  • Previous
  • Next
  • 1
  • …
  • 331
  • 332
  • 333
  • 334
  • 335
  • 336
  • 337
  • 338
  • 339
  • …
  • 799

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire